1. Drug Policy in China Transformations, Current Status and Future Prospects

   • Xingzhu Liu
   • Shixue Li

   Leading Article 25 November 2012 Pages: 1 - 9

2. Publication Bias in Clinical Trials and Economic Analyses

   • Nick Freemantle
   • James Mason

   Leading Article 25 November 2012 Pages: 10 - 16

3. Cost Effectiveness of the Prevention and Treatment of Deep Vein Thrombosis and Pulmonary Embolism

   • David R. Anderson
   • Bernie J. O’Brien

   Review Article 25 November 2012 Pages: 17 - 29

4. Economics of Thromboprophylaxis in Total Hip Replacement Surgery

   • Jeff Harrison
   • David J. Warwick
   • Joanna Coast

   Review Article 25 November 2012 Pages: 30 - 41

5. Cost-Effective Management of Diabetic Foot Ulcers

   • Gunnel Ragnarson-Tennvall
   • Jan Apelqvist

   Review Article 25 November 2012 Pages: 42 - 53

6. Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection

   • Jeremy V. Chancellor
   • Andrew M. Hill
   • Mike Youle

   Original Research Article 25 November 2012 Pages: 54 - 66

7. Economic Evaluation of ACE Inhibitor Treatment of Nephropathy in Patients with Insulin-Dependent Diabetes Mellitus in Italy

   • Livio Garattini
   • Massimo Brunetti
   • Mattia Barosi

   Original Research Article 25 November 2012 Pages: 67 - 75

8. Analysis of the Costs of NSAID-Associated Gastropathy

   • Richard E. Johnson
   • Mark C. Hornbrook
   • Robert Shneidman

   Original Research Article 25 November 2012 Pages: 76 - 88

9. Cost-Utility Analysis of Melphalan plus Prednisone With or Without Interferon-α2b in Newly Diagnosed Multiple Myeloma

   • Erik Nord
   • Finn Wisøff
   • Jan Westin

   Original Research Article 25 November 2012 Pages: 89 - 103

10. Glossary

    News 25 November 2012 Pages: 104 - 107